Sialic acid and sialyl-lactose glyco-conjugates: design, synthesis and binding assays to lectins and swine influenza H1N1 virus.
Study Design
- Type d'étude
- Other
- Population
- None
- Intervention
- Sialic acid and sialyl-lactose glyco-conjugates: design, synthesis and binding assays to lectins and swine influenza H1N1 virus. None
- Comparateur
- None
- Critère de jugement principal
- None
- Direction de l'effet
- Mixed
- Risque de biais
- Unclear
Abstract
The terminal parts of the influenza hemagglutinin (HA) receptors α2,6- and α2,3-sialyllactoses were conjugated to an artificial carrier, named sequential oligopeptide carrier (SOC(4) ), to formulate human and avian receptor mimics, respectively. SOC(4) , formed by the tripeptide unit Lys-Aib-Gly, adopts a rigid helicoids-type conformation, which enables the conjugation of biomolecules to the Lys-N(ε) H(2) groups. By doing so, it preserves their initial conformations and functionalities of the epitopes. We report that SOC(4) -glyco-conjugate bearing two copies of the α2,6-sialyllactose is specifically recognized by the biotinylated Sambucus nigra (elderberry) bark lectin, which binds preferentially to sialic acid in an α2,6-linkage. SOC(4) -glyco-conjugate bearing two copies of the α2,3-sialyllactose was not recognized by the biotinylated Maackia amurensis lectin, despite its well-known α2,3-sialyl bond specificity. However, preliminary immune blot assays showed that H1N1 virus binds to both the SOC(4) -glyco-conjugates immobilized onto nitrocellulose membrane. It is concluded that Ac-SOC(4) [(Ac)(2) ,(3'SL-Aoa)(2) ]-NH(2) 5 and Ac-SOC(4) [(Ac)(2) ,(6'SL-Aoa)(2) ]-NH(2) 6 mimic the HA receptors. These findings could be useful for easy screening of binding and inhibition assays of virus-receptor interactions.
En bref
Preliminary immune blot assays showed that H1N1 virus binds to both the SOC4‐glyco‐conjugates immobilized onto nitrocellulose membrane, which could be useful for easy screening of binding and inhibition assays of virus–receptor interactions.
Used In Evidence Reviews
Similar Papers
The Journal of international medical research · 2004
Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections.
Phytochemistry · 2009
Elderberry flavonoids bind to and prevent H1N1 infection in vitro.
Journal of alternative and complementary medicine (New York, N.Y.) · 1995
Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama.
Alternative medicine review : a journal of clinical therapeutic · 2007
Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations.
BMC complementary and alternative medicine · 2011
Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses.
Complementary therapies in medicine · 2019